Showing results (4141-4150 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 18, 2024
A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trialMarie S Dreyer, Mary Mulcahy, Masha Kocherginsky, et al.
The Oncologist|September 18, 2024
Real-world treatment patterns and outcomes of patients with advanced melanoma treated with nivolumab plus relatlimabSach Thakker, Micah Belzberg, Sekwon Jang, et al.
The Oncologist|August 3, 2024
High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directionsKartik R Patel, Soroush Rais-Bahrami, Arnab Basu
The Oncologist|May 14, 2025
Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecanAnna Amela Valsecchi, Simona Pisegna, Andrea Antonuzzo, et al.
The Oncologist|May 16, 2025
Barriers to adherence to cervical cancer screening care in Northern TanzaniaTecla Lyamuya, Bariki Mchome, Clara Yolanda Stroetmann, et al.
The Oncologist|May 11, 2025
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBCNaoto T Ueno, Francesco Cottone, Kyle Dunton, et al.
The Oncologist|April 26, 2025
Identifying predictors of overall survival among patients with TMB-low metastatic cancer treated with immune checkpoint inhibitorsCamila Braganca Xavier, Gabriela D A Guardia, João Pedro B Alves, et al.
The Oncologist|May 8, 2025
Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patientsMorten Ladekarl, Mette Louise Mørk, Emma Skotte Albertsen, et al.
The Oncologist|April 30, 2025
Examining the evolving landscape of kidney cancer mortality in the United StatesMelis Guer, Chinmay Jani, Georgina Hanbury, et al.
The Oncologist|March 31, 2025
Balancing immunotherapy and corticosteroids in cancer treatment: dilemma or paradox?Alessandro Ottaiano, Mariachiara Santorsola, Maurizio Capuozzo, et al.
Pageof 571